!!Projects per year
個人檔案
學歷
- 2018 國立陽明大學臨床醫學研究所博士
- 2003 國防醫學院醫學系學士
經歷
- 衛生福利部雙和醫院婦產部主任
- 衛生福利部雙和醫院婦產部婦科主任
- 衛生福利部雙和醫院婦產部婦產科主治醫師
- 2023.02- 臺北醫學大學醫學系婦產學科副教授
- 臺北醫學大學醫學系婦產學科助理教授
- 2012.05-2019.03 臺北榮總醫院婦產部主治醫師
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
-
透過子宮頸拭子之 DNA 甲基化生物標記來評估與偵測卵巢腫瘤的風險(2/3)
Wen, K.-C. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
研發新的DNA甲基化生物標誌以提高自我採檢MPap的性能(MPap 2.0)(2/2)
Wen, K.-C. (PI)
8/1/23 → 7/31/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
研發新的DNA甲基化生物標誌以提高自我採檢MPap的性能(MPap 2.0)(1/2)
Wen, K.-C. (PI)
8/1/22 → 7/31/23
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or Worse
Chen, C. C., Hsiao, K. Y., Lu, S. C., Bai, C. H., Wen, K. C. & Wang, Y. H., 2026, 於: Journal of Lower Genital Tract Disease. 30, 2, p. 100-109 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Programmed death-ligand 1 upregulation is associated with poor prognosis in patients with epithelial ovarian cancer
Liu, C. H., Chao, W. T., Yang, S. T., Lin, C. H., Wen, K. C. & Wang, P. H., 2026, 於: Journal of the Chinese Medical Association. 89, 1, p. 25-34 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取15 連結會在新分頁中打開 引文 斯高帕斯(Scopus) -
A DNA methylation assay (MPap) using self-collected tampon versus cytology collection swab for endometrial cancer detection
Su, K. M., Wen, K. C., Lin, Y. H., Su, P. H., Chen, L. Y. & Lai, H. C., 2025, 於: International Journal of Gynecology and Obstetrics. 173, 3, p. 1400-1407 8 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Combined pembrolizumab and bevacizumab therapy in heavily treated recurrent ovarian cancer
Wang, S.-Y., Chou, Y. T., Wen, K.-C., Liew, P.-L., Lu, Y.-H., Chen, L.-Y., Sung, P. L., Lai, H.-C. & Chu, L.-H., 8月 2025, 於: European Journal of Gynaecological Oncology. 46, 8, p. 48研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Exploring potential methylation markers for ovarian cancer from cervical scraping samples
Lien, J. Y., Hii, L. A., Su, P. H., Chen, L. Y., Wen, K. C., Lai, H. C. & Wang, Y. C., 12月 2025, 於: Human Genomics. 19, 1, 56.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 連結會在新分頁中打開 引文 斯高帕斯(Scopus)
資料集
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
資料集: Dataset
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
資料集: Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
資料集: Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
資料集: Dataset
-
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Wu, A. T. H. (Creator), Yeung, S.-C. J. (Contributor), Wen, K.-C. (Creator), Chou, P.-C. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor) & Sung, P.-L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845531.v1, https://doi.org/10.6084%2Fm9.figshare.12845531.v1
資料集: Dataset